In addition, we found that aspirin could exert antitumor effects in ESCC cells by inhibiting the expression of ATAD2 and KIF4A.These results suggested that ATAD2 correlated with the malignant status and could potentially serve as a therapeutic target in ESCC. This evidence concerns the gene ATAD2 and esophageal squamous cell carcinoma.